{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:09:01Z","timestamp":1793758141358,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52357-8","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T13:04:57Z","timestamp":1726146297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7797-9080","authenticated-orcid":false,"given":"Stephen","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4139-7780","authenticated-orcid":false,"given":"Sophie","family":"Higham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plamena","family":"Naydenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-4446","authenticated-orcid":false,"given":"Josefin Bartholdson","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Harcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"To Nguyen","family":"Thi Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Duc","family":"Toan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Alekseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sobotic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Forrest-Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana Moreno","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-0564","authenticated-orcid":false,"given":"Leah","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-5742","authenticated-orcid":false,"given":"Simon","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Clare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9098-8590","authenticated-orcid":false,"given":"Mili Estee","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3166-4734","authenticated-orcid":false,"given":"Paul","family":"Kellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8093-8741","authenticated-orcid":false,"given":"John S.","family":"Tregoning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-6271","authenticated-orcid":false,"given":"Stephen T.","family":"Reece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"52357_CR1","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","volume":"48","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim, S., Al-Saryi, N., Al-Kadmy, I. M. S. & Aziz, S. N. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol. Biol. Rep. 48, 6987\u20136998 (2021).","journal-title":"Mol. Biol. Rep."},{"key":"52357_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nrmicro1789","volume":"5","author":"L Dijkshoorn","year":"2007","unstructured":"Dijkshoorn, L., Nemec, A. & Seifert, H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5, 939\u2013951 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"52357_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"52357_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/CMR.00058-16","volume":"30","author":"D Wong","year":"2017","unstructured":"Wong, D. et al. Clinical and pathophysiological overview of acinetobacter infections: a century of challenges. Clin. Microbiol. Rev. 30, 409\u2013447 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"52357_CR5","doi-asserted-by":"crossref","unstructured":"Peleg, A. Y., Seifert, H. & Paterson, D. L. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538\u2013582 (2008).","DOI":"10.1128\/CMR.00058-07"},{"key":"52357_CR6","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3201\/eid1506.081006","volume":"15","author":"Y Doi","year":"2009","unstructured":"Doi, Y., Husain, S., Potoski, B. A., McCurry, K. R. & Paterson, D. L. Extensively Drug-Resistant Acinetobacter baumannii.Emerg. Infect. Dis. 15, 980\u2013982 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"52357_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/1469-0691.12363","volume":"20","author":"EV Lemos","year":"2014","unstructured":"Lemos, E. V. et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin. Microbiol. Infect. 20, 416\u2013423 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"52357_CR8","doi-asserted-by":"publisher","unstructured":"Jesudason, T. WHO publishes updated list of bacterial priority pathogens. Lancet Microbe 100940. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.003 (2024).","DOI":"10.1016\/j.lanmic.2024.07.003"},{"key":"52357_CR9","doi-asserted-by":"publisher","first-page":"e239694","DOI":"10.1001\/jamanetworkopen.2023.9694","volume":"6","author":"N Ambrose","year":"2023","unstructured":"Ambrose, N. et al. Neutralizing monoclonal antibody use and COVID-19 infection outcomes. Jama Netw. Open 6, e239694 (2023).","journal-title":"Jama Netw. Open"},{"key":"52357_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","volume":"19","author":"F Micoli","year":"2021","unstructured":"Micoli, F., Bagnoli, F., Rappuoli, R. & Serruto, D. The role of vaccines in combatting antimicrobial resistance. Nat. Rev. Microbiol. 19, 287\u2013302 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"52357_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81629","volume":"12","author":"E Richardson","year":"2023","unstructured":"Richardson, E. et al. Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing. Elife 12, e81629 (2023).","journal-title":"Elife"},{"key":"52357_CR12","doi-asserted-by":"publisher","first-page":"e00162","DOI":"10.1128\/IAI.00162-21","volume":"89","author":"TB Nielsen","year":"2021","unstructured":"Nielsen, T. B. et al. Monoclonal antibody therapy against acinetobacter baumannii. Infect. Immun. 89, e00162\u201321 (2021).","journal-title":"Infect. Immun."},{"key":"52357_CR13","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2666-5247(20)30126-9","volume":"1","author":"S Baker","year":"2020","unstructured":"Baker, S., Kellam, P., Krishna, A. & Reece, S. Protecting intubated patients from the threat of antimicrobial resistant infections with monoclonal antibodies. Lancet Microbe 1, e191\u2013e192 (2020).","journal-title":"Lancet Microbe"},{"key":"52357_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-micro-052821-031444","volume":"75","author":"MG Sartorio","year":"2021","unstructured":"Sartorio, M. G., Pardue, E. J., Feldman, M. F. & Haurat, M. F. Bacterial outer membrane vesicles: from discovery to applications. Annu. Rev. Microbiol. 75, 1\u201322 (2021).","journal-title":"Annu. Rev. Microbiol."},{"key":"52357_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrmicro3525","volume":"13","author":"C Schwechheimer","year":"2015","unstructured":"Schwechheimer, C. & Kuehn, M. J. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat. Rev. Microbiol. 13, 605\u2013619 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"52357_CR16","doi-asserted-by":"publisher","first-page":"828704","DOI":"10.3389\/fmicb.2022.828704","volume":"13","author":"DN Villageliu","year":"2022","unstructured":"Villageliu, D. N. & Samuelson, D. R. The role of bacterial membrane vesicles in human health and disease. Front. Microbiol. 13, 828704 (2022).","journal-title":"Front. Microbiol."},{"key":"52357_CR17","doi-asserted-by":"publisher","unstructured":"Higham, S. L. et al. Intranasal immunisation with Outer Membrane Vesicles (OMV) protects against airway colonisation and systemic infection with Acinetobacter baumannii 1 1 Current addresses: KF UCL. J. Infecti. https:\/\/doi.org\/10.1016\/j.jinf.2023.02.035 (2023).","DOI":"10.1016\/j.jinf.2023.02.035"},{"key":"52357_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nbt.2825","volume":"32","author":"E-C Lee","year":"2014","unstructured":"Lee, E.-C. et al. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery. Nat. Biotechnol. 32, 356\u2013363 (2014).","journal-title":"Nat. Biotechnol."},{"key":"52357_CR19","doi-asserted-by":"publisher","first-page":"e0170721","DOI":"10.1128\/mBio.01707-21","volume":"12","author":"Antenucci Zhu","year":"2021","unstructured":"Zhu, Antenucci, Zhuang, Villumsen, Fabio, Bojesen, Kasper R\u00f8mer & Anders, Miki Bacterial outer membrane vesicles as a versatile tool in vaccine research and the fight against antimicrobial resistance. mBio 12, e0170721 (2021).","journal-title":"mBio"},{"key":"52357_CR20","doi-asserted-by":"publisher","first-page":"629090","DOI":"10.3389\/fmicb.2021.629090","volume":"12","author":"MD Balhuizen","year":"2021","unstructured":"Balhuizen, M. D., Veldhuizen, E. J. A. & Haagsman, H. P. Outer membrane vesicle induction and isolation for vaccine development. Front. Microbiol. 12, 629090 (2021).","journal-title":"Front. Microbiol."},{"key":"52357_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fmicb.2017.01053","volume":"8","author":"AT Jan","year":"2017","unstructured":"Jan, A. T. Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: a perspective update. Front. Microbiol. 8, 1053 (2017).","journal-title":"Front. Microbiol."},{"key":"52357_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Cell 183, 1367\u20131382.e17 (2020).","journal-title":"Cell"},{"key":"52357_CR23","volume":"2","author":"Schultz","year":"2016","unstructured":"Schultz et al. Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward. Micro. Genom. 2, e000050 (2016).","journal-title":"Micro. Genom."},{"key":"52357_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.drup.2012.06.001","volume":"15","author":"N Karah","year":"2012","unstructured":"Karah, N., Sundsfjord, A., Towner, K. & Samuelsen, \u00d8. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist. Update 15, 237\u2013247 (2012).","journal-title":"Drug Resist. Update"},{"key":"52357_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1099\/jmm.0.037523-0","volume":"61","author":"Wand","year":"2012","unstructured":"Wand et al. Acinetobacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation. J. Med. Microbiol. 61, 470\u2013477 (2012).","journal-title":"J. Med. Microbiol."},{"key":"52357_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/imr.13147","volume":"313","author":"A Zarantonello","year":"2023","unstructured":"Zarantonello, A., Revel, M., Grunenwald, A. & Roumenina, L. T. C3\u2010dependent effector functions of complement. Immunol. Rev. 313, 120\u2013138 (2023).","journal-title":"Immunol. Rev."},{"key":"52357_CR27","doi-asserted-by":"publisher","first-page":"e0000875","DOI":"10.1371\/journal.pgph.0000875","volume":"2","author":"ND Toan","year":"2022","unstructured":"Toan, N. D. et al. Clinical and laboratory factors associated with neonatal sepsis mortality at a major Vietnamese children\u2019s hospital. Plos Glob. Public Health 2, e0000875 (2022).","journal-title":"Plos Glob. Public Health"},{"key":"52357_CR28","doi-asserted-by":"publisher","first-page":"e857","DOI":"10.1016\/S2666-5247(22)00181-1","volume":"3","author":"LW Roberts","year":"2022","unstructured":"Roberts, L. W. et al. Genomic characterisation of multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: a prospective observational cohort study. Lancet Microb. 3, e857\u2013e866 (2022).","journal-title":"Lancet Microb."},{"key":"52357_CR29","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1128\/AAC.02522-13","volume":"58","author":"NT Antunes","year":"2014","unstructured":"Antunes, N. T. et al. Class D \u03b2-Lactamases: are they all carbapenemases? Antimicrob. Agents Chemother. 58, 2119\u20132125 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"52357_CR30","doi-asserted-by":"publisher","first-page":"e107833","DOI":"10.1371\/journal.pone.0107833","volume":"9","author":"Nigro Kenyon","year":"2014","unstructured":"Kenyon, Nigro., Johanna, J., Hall, Steven, J. & Ruth, M. Variation in the OC locus of Acinetobacter baumannii genomes predicts extensive structural diversity in the lipooligosaccharide. PLoS ONE 9, e107833 (2014).","journal-title":"PLoS ONE"},{"key":"52357_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01836-21","volume":"12","author":"MMB Mart\u00ednez","year":"2021","unstructured":"Mart\u00ednez, M. M. B. et al. On the offensive: the role of outer membrane vesicles in the successful dissemination of new delhi Metallo-\u03b2-lactamase (NDM-1). mBio 12, e0183621 (2021).","journal-title":"mBio"},{"key":"52357_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nchembio.2083","volume":"12","author":"LJ Gonz\u00e1lez","year":"2016","unstructured":"Gonz\u00e1lez, L. J. et al. Membrane anchoring stabilizes and favors secretion of New Delhi metallo-\u03b2-lactamase. Nat. Chem. Biol. 12, 516\u2013522 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"52357_CR33","doi-asserted-by":"crossref","unstructured":"Wyres, K. L. et al. Identification of acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb. Genom. 6, e000339 (2020).","DOI":"10.1099\/mgen.0.000339"},{"key":"52357_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104045","volume":"80","author":"G Altamirano","year":"2022","unstructured":"Altamirano, G. et al. Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. EBioMedicine 80, 104045 (2022).","journal-title":"EBioMedicine"},{"key":"52357_CR35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/antibiotics11050677","volume":"11","author":"K Abdelkader","year":"2022","unstructured":"Abdelkader, k. et al. The specific capsule depolymerase of phage PMK34 sensitizes acinetobacter baumannii to Serum Killing. Antibiotics 11, 677 (2022).","journal-title":"Antibiotics"},{"key":"52357_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/infdis\/jiac499","volume":"227","author":"TB Nielsen","year":"2023","unstructured":"Nielsen, T. B. et al. Development of a bispecific antibody targeting clinical isolates of acinetobacter baumannii. J. Infect. Dis. 227, 1042\u20131049 (2023).","journal-title":"J. Infect. Dis."},{"key":"52357_CR37","first-page":"e00086","volume":"67","author":"M Slarve","year":"2023","unstructured":"Slarve, M. et al. Therapeutic, humanized monoclonal antibody exhibits broad binding and protective efficacy against acinetobacter baumannii. Antimicrob. Agents Chemother. 67, e00086\u201323 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"52357_CR38","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1038\/srep08643","volume":"5","author":"H-Y Ou","year":"2015","unstructured":"Ou, H.-Y. et al. Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors. Sci. Rep. 5, 8643 (2015).","journal-title":"Sci. Rep."},{"key":"52357_CR39","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1093\/cid\/ciy691","volume":"67","author":"K Zhou","year":"2018","unstructured":"Zhou, K. et al. An Emerging Clone (ST457) of acinetobacter baumannii Clonal Complex 92 with enhanced virulence and increasing endemicity in South China. Clin. Infect. Dis. 67, S179\u2013S188 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"52357_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.07.002","volume":"473","author":"S Fischinger","year":"2019","unstructured":"Fischinger, S. et al. A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation. J. Immunol. Methods 473, 112630 (2019).","journal-title":"J. Immunol. Methods"},{"key":"52357_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69300-8","volume":"10","author":"M Maes","year":"2020","unstructured":"Maes, M. et al. A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131. Sci. Rep. 10, 12414 (2020).","journal-title":"Sci. Rep."},{"key":"52357_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/CVI.13.3.333-340.2006","volume":"13","author":"ST Reece","year":"2006","unstructured":"Reece, S. T. et al. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Clin. Vaccin. Immunol. 13, 333\u2013340 (2006).","journal-title":"Clin. Vaccin. Immunol."},{"key":"52357_CR43","first-page":"91","volume":"94","author":"D Lodes","year":"2004","unstructured":"Lodes, D. et al. A. Expression cloning. Methods Mol. Med. 94, 91\u2013106 (2004).","journal-title":"Methods Mol. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52357-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52357-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52357-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T13:05:35Z","timestamp":1726146335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52357-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52357"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52357-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"1 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests. J.B.S., Q.Z., and S.T.R. are employees of Kymab Ltd, a Sanofi company and may have held or continue to hold stock options or shares in Sanofi. S.O\u2019.L., J.B.S., A.K., S.W., S.T.R., and S.B. are listed as inventors on a published patent WO2023094628A1 covering monoclonal antibodies generated by this work. S.O\u2019.L., A.K., I.A., B.S., H.C., V.W., N.F.O., D.M.S., C.P., S.W., and P.K. were employees of Kymab, a Sanofi Company within the last three years and may have held or continue to hold stock options or shares in Sanofi. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7979"}}